NOVEL(SZ:002014) Western Securities·2025-11-09 12:57Investment Rating - The investment rating for the company is "Buy" [5] Core Insights - The company reported a steady revenue growth of 6.56% year-on-year for the first three quarters of 2025, achieving a total revenue of 2.706 billion yuan, with a net profit attributable to shareholders of 309 million yuan, reflecting a 1.43% increase [1][2] - In Q3 2025, the company generated revenue of 960 million yuan, marking an 8.02% year-on-year growth, and a net profit of 126 million yuan, up by 1.00% [1][2] - The company is advancing its capacity expansion projects, with half of the new functional film material production capacity already operational and full production expected by H1 2026 [1] - The gross margin for the first three quarters of 2025 was 22.33%, a decrease of 0.63 percentage points year-on-year, while Q3 2025 saw a gross margin of 24.44%, an increase of 0.38 percentage points year-on-year [2] - The company anticipates revenue growth of 7.4%, 9.2%, and 9.8% for the years 2025, 2026, and 2027, respectively, with net profits expected to grow by 2.3%, 9.5%, and 13.6% in the same period [2] Summary by Sections Financial Performance - For Q1-Q3 2025, the company achieved a revenue of 2.706 billion yuan, with a net profit of 309 million yuan [1] - The gross margin for Q1-Q3 2025 was 22.33%, while Q3 2025 saw a gross margin of 24.44% [2] - The net profit margin for Q1-Q3 2025 was 11.43%, and for Q3 2025, it was 13.12% [2] Future Projections - Revenue projections for 2025, 2026, and 2027 are 3.788 billion yuan, 4.135 billion yuan, and 4.542 billion yuan, respectively [2] - Net profit projections for the same years are 478 million yuan, 524 million yuan, and 595 million yuan, respectively [2] - The expected EPS for 2025, 2026, and 2027 is 0.78 yuan, 0.86 yuan, and 0.97 yuan, respectively [2]